pharma · Cystic Fibrosis · Rheumatoid Arthritis · LKFT
Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV clinical programs — 62 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Yalelaan 60, 5th floor, Utrecht 3584 CM, NL
- Founded
- 2016
- Employees
- 9
- Programs
- 99
- Drugs
- 26
- Patents
- 0
Lakefront Biotherapeutics NV projects
62 ClinicalTrials.gov programs sponsored by Lakefront Biotherapeutics NV.
Lakefront Biotherapeutics NV has 62 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
GLPG3667
Lakefront Biotherapeutics NV
Plaque Psoriasis
1 trial -
GLPG3667 capsule
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG3667 oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG3970 film-coated tablet
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG3970 film-coated tablet
Lakefront Biotherapeutics NV
Systemic Lupus Erythematosus
1 trial -
GLPG3970 oral solution
Lakefront Biotherapeutics NV
Healthy
2 trials -
GLPG4059 oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG4399 oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
GLPG4716
Lakefront Biotherapeutics NV
Healthy
1 trial -
MOR106
Lakefront Biotherapeutics NV
Healthy
1 trial -
MOR106 single ascending doses, intravenous
Lakefront Biotherapeutics NV
Healthy
1 trial -
Pirfenidone
Lakefront Biotherapeutics NV
Healthy
1 trial -
Sulfasalazine
Lakefront Biotherapeutics NV
Healthy
1 trial -
placebo
Lakefront Biotherapeutics NV
Healthy
1 trial
Frequently asked questions
How many clinical projects does Lakefront Biotherapeutics NV have?
62 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.